Preparatory neuronal activity in ALM is decreased, but remains significant in quiet trials devoid of movements. by Vahid Esmaeili (12700352)

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Top 20 genes with significantly decreased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Significantly changed USSs in the sf3b1 mutants. by Bei Zhang (428038)

Interaction of significantly changed genes and their linked pathways. by Mohamad Ammar Ayass (13775290)

Geniposide(Gen) significantly decreased the levels of TNF-α and MIP-1α in BALF of bleomycin-induced PF mice. by Jian-Bin Yin (19556105)

IRI group exhibited a significantly greater decrease in proportion of gambles accepted compared to the IRI group in the second block. by Yasuhiro Mochizuki (3308349)

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)

Both MRI and SR-PCI demonstrated significant decreases in clinically-relevant articular cartilage parameters. by Suranjan Bairagi (17087667)

GTDE effectively reduced d-gal-induced oxidative stress and increased the expression levels of antioxidant proteins and BDNF. by Hui-Chuan Kuo (12368492)

Subjects:

The application of GTDE efficiently increased the D-gal induced decline in the expression levels of BDNE. by Hui-Chuan Kuo (12368492)

Subjects:

Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

Subjects:

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Changes in outcomes over time. by Jae-Heung Cho (798319)

“…When a “willingness to pay for treatment ($26,375)” threshold was applied, the probability of CMT being cost-effective was 68.1%–98.3%. Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …”

Changes in FMD (% ± SD) in patient subgroup with decreased body weight during observation period. by Haruka Tamura (153793)

Percent change in yearly crude rates (between 2019 and 2021 and between 2019 and 2024) by gender and state. by Tony Wong (779773)

Subjects:

Targets of the study. by Wenwen Yin (1877125)

Subjects:

Identified plasma proteins and those significantly affected by the placebo treatment. by Karin Meissner (69350)

Subjects:

Significant difference in staff change readiness over time. by Chiara Pomare (7868000)

Subjects:

ACT and ISO decrease pathological changes in LPS-induced AKI mice. by Jing Lian (1671991)